Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Анализ на конкурентни рискове с коригирана спрямо риска× | Анализ на преживяемостта× | |
|---|---|---|
| Област≠ | Епидемиология | Статистика за изследвания |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 1999 (subdistribution hazard model); cause-specific hazard framework earlier | 1958 |
| Създател≠ | Jason Fine and Robert Gray | Edward L. Kaplan and Paul Meier |
| Тип≠ | Regression model for time-to-event data with competing events | Method |
| Основополагащ източник≠ | Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509. DOI ↗ | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ |
| Други названия≠ | competing risks regression, subdistribution hazard model, cause-specific hazard analysis, Fine-Gray model | Kaplan-Meier analysis, Cox regression, TTE analysis |
| Свързани≠ | 4 | 3 |
| Резюме≠ | Risk-adjusted competing risks analysis extends classical survival analysis to settings where subjects can experience more than one type of terminal event, and where the occurrence of one event prevents the occurrence of another. By modelling cause-specific or subdistribution hazards while adjusting for measured confounders, the method yields unbiased estimates of the absolute probability — the cumulative incidence function — of each event type over time in the presence of competing events. | Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters. |
| ScholarGateНабор от данни ↗ |
|
|